LANDSCAPE OF KRAS G12C MUTATIONS IN GENITOURINARY MALIGNANCIES

被引：0
|
作者：
Rebecca, Sager A.
Michael, Basin F.
Hanan, Goldberg
Jeffrey, Ross S.
Gennady, Bratslavsky
Joseph, Jacob M.
Petros, Grivas
Andrea, Necchi
机构：
[1] SUNY Upstate Med Univ, Syracuse, NY 13210 USA
[2] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA
[3] Univ Vita Salute San Raffaele, Milan, Italy
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2024年 / 42卷
关键词：
D O I：
10.1016/j.urolonc.2024.01.198
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
161
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [41] Overcoming resistance to KRAS G12C inhibitors in lung cancer
    Ambrogio, Chiara
    CANCER SCIENCE, 2023, 114 : 987 - 987
  • [42] Expanding the Arsenal of Clinically Active KRAS G12C Inhibitors
    Arbour, Kathryn C.
    Lito, Piro
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (23) : 2609 - +
  • [43] Breaking barriers: the latest insights into KRAS G12C inhibitors
    Attieh, Fouad
    Kourie, Hampig Raphael
    FUTURE ONCOLOGY, 2024, 20 (35) : 2685 - 2688
  • [44] G12C KRAS mutant colorectal cancer, optimising the target
    Price, T. J.
    ANNALS OF ONCOLOGY, 2024, 35 : S1300 - S1300
  • [45] Diverse alterations associated with resistance to KRAS(G12C) inhibition
    Zhao, Yulei
    Murciano-Goroff, Yonina R.
    Xue, Jenny Y.
    Ang, Agnes
    Lucas, Jessica
    Mai, Trang T.
    Da Cruz Paula, Arnaud F.
    Saiki, Anne Y.
    Mohn, Deanna
    Achanta, Pragathi
    Sisk, Ann E.
    Arora, Kanika S.
    Roy, Rohan S.
    Kim, Dongsung
    Li, Chuanchuan
    Lim, Lee P.
    Li, Mark
    Bahr, Amber
    Loomis, Brian R.
    de Stanchina, Elisa
    Reis-Filho, Jorge S.
    Weigelt, Britta
    Berger, Michael
    Riely, Gregory
    Arbour, Kathryn C.
    Lipford, J. Russell
    Li, Bob T.
    Lito, Piro
    NATURE, 2021, 599 (7886) : 679 - +
  • [46] Sotorasib for Vascular Malformations Associated with KRAS G12C Mutation
    Fraissenon, Antoine
    Bayard, Charles
    Morin, Gabriel
    Benichi, Sandro
    Hoguin, Clement
    Protic, Sanela
    Zerbib, Lola
    Ladraa, Sophia
    Firpion, Marina
    Blauwblomme, Thomas
    Naggara, Olivier
    Duruisseaux, Michael
    Delous, Marion
    Boitel, Clothilde
    Bringuier, Pierre-Paul
    Payen, Lea
    Legendre, Christophe
    Kaltenbach, Sophie
    Balducci, Estelle
    Villarese, Patrick
    Asnafi, Vahid
    Bisdorff, Annouk
    Guibaud, Laurent
    Canaud, Guillaume
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (04): : 334 - 342
  • [47] ONCOGENIC KRAS G12C MUTATION DERIVED INHIBITOR DEVELOPMENT
    Leveles, Ibolya
    Koppany, Gergely
    Nyiri, Kinga
    Vertessy, G. Beata
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2019, 75 : E117 - E117
  • [48] Potent and Selective Covalent Quinazoline Inhibitors of KRAS G12C
    Zeng, Mei
    Lu, Jia
    Li, Lianbo
    Feru, Frederic
    Quan, Chunshan
    Gero, Thomas W.
    Ficarro, Scott B.
    Xiong, Yuan
    Ambrogio, Chiara
    Paranal, Raymond M.
    Catalano, Marco
    Shao, Jay
    Wong, Kwok-Kin
    Marto, Jarrod A.
    Fischer, Eric S.
    Janne, Pasi A.
    Scott, David A.
    Westover, Kenneth D.
    Gray, Nathanael S.
    CELL CHEMICAL BIOLOGY, 2017, 24 (08): : 1005 - +
  • [49] KRAS G12C inhibition with sotorasib in metastatic colorectal cancer
    Severi, Christophe
    Van Cutsem, Eric
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (08) : 2792 - 2795
  • [50] KRAS G12C Inhibitors: New Drugs, A New Hope
    Singhal, Surbhi
    Schokrpur, Shiruyeh
    Gandara, David
    Riess, Jonathan W.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (12) : 1594 - 1598
12345